Home LiteratureArticle Details
PMID: 6151066 Published · ppublish English Clinical Trial Letter Randomized Controlled Trial Research Support, Non-U.S. Gov't

Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis.

Lancet (London, England) ·Vol. 2 ·No. 8417-8418 ·1984-12-22 ·Pages 1462-3

Judson FN, Ehret JM

Abstract

暂无摘要

MeSH Terms
Cefotaxime/administration & dosage,analogs & derivatives,pharmacology Ceftriaxone Female Gonorrhea/microbiology Humans Male Neisseria meningitidis/drug effects,isolation & purification Pharynx/microbiology Pilot Projects
Chemicals
Ceftriaxone Cefotaxime
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Judson F N
Ehret J M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(84)91647-7
Published
1984-12-22
Pages
1462-3
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(84)91647-7 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2